Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Best Practices for Preventing Statistical Pitfa...
By
Charmi Patel
July 5, 2024
Introduction Statistics form the base of Health Economics and Outcomes Research (HEOR), enabling researchers to draw meaningful conclusion...
Transformation of Health Technology Assessment in Türkiye
Fremanezumab: Cost-Effective Relief for Chronic Migraine
Mental Health Disparities in South and East Asia: Research Priorities and Col...
Pharmacoeconomic Comparison of Anaprazole and Ilaprazole for Duodenal Ulcer T...
The Role of Real-World Evidence in CMS Price Negotiations
Enhancing Global Health through Cost-Effectiveness Analysis
The Role of Pull Incentives in Addressing Antimicrobial Resistance
A Cost-Saving Life-Saver: The Impact of Palivizumab in Columbia
Tuberculosis Care in Indonesia: A Financial Analysis of Strategic Purchasing ...
Cost-Effectiveness of IDegAsp in Diabetes Management: Insights from ARISE Study
Understanding the Cost and Clinical Impact of Multisystem Inflammatory Syndro...
Striking the Balance: Optimising Hepatitis B Treatment Strategies in The Gambia
« Previous
1
…
19
20
21
22
23
…
41
Next »